25 XP   0   0   10

Zhejiang Anglikang Pharmaceutical Co Ltd Class A
Buy, Hold or Sell?

Let's analyse Zhejiang Anglikang Pharmaceutical Co Ltd Class A together

PenkeI guess you are interested in Zhejiang Anglikang Pharmaceutical Co Ltd Class A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Anglikang Pharmaceutical Co Ltd Class A

I send you an email if I find something interesting about Zhejiang Anglikang Pharmaceutical Co Ltd Class A.

Quick analysis of Zhejiang Anglikang Pharmaceutical Co Ltd Class A (30 sec.)










What can you expect buying and holding a share of Zhejiang Anglikang Pharmaceutical Co Ltd Class A? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥8.98
Expected worth in 1 year
¥10.15
How sure are you?
94.7%

+ What do you gain per year?

Total Gains per Share
¥1.44
Return On Investment
9.1%

For what price can you sell your share?

Current Price per Share
¥15.84
Expected price per share
¥11.84 - ¥17.29
How sure are you?
50%

1. Valuation of Zhejiang Anglikang Pharmaceutical Co Ltd Class A (5 min.)




Live pricePrice per Share (EOD)

¥15.84

Intrinsic Value Per Share

¥7.04 - ¥8.17

Total Value Per Share

¥16.02 - ¥17.15

2. Growth of Zhejiang Anglikang Pharmaceutical Co Ltd Class A (5 min.)




Is Zhejiang Anglikang Pharmaceutical Co Ltd Class A growing?

Current yearPrevious yearGrowGrow %
How rich?$250.7m$211m$33.6m13.8%

How much money is Zhejiang Anglikang Pharmaceutical Co Ltd Class A making?

Current yearPrevious yearGrowGrow %
Making money$4.4m$5.2m-$834.2k-18.7%
Net Profit Margin7.5%10.5%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Anglikang Pharmaceutical Co Ltd Class A (5 min.)




What can you expect buying and holding a share of Zhejiang Anglikang Pharmaceutical Co Ltd Class A? (5 min.)

Welcome investor! Zhejiang Anglikang Pharmaceutical Co Ltd Class A's management wants to use your money to grow the business. In return you get a share of Zhejiang Anglikang Pharmaceutical Co Ltd Class A.

What can you expect buying and holding a share of Zhejiang Anglikang Pharmaceutical Co Ltd Class A?

First you should know what it really means to hold a share of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Anglikang Pharmaceutical Co Ltd Class A is ¥15.84. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Anglikang Pharmaceutical Co Ltd Class A.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Anglikang Pharmaceutical Co Ltd Class A, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥8.98. Based on the TTM, the Book Value Change Per Share is ¥0.29 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.20 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Anglikang Pharmaceutical Co Ltd Class A.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.020.1%0.030.2%0.020.1%0.020.1%
Usd Book Value Change Per Share0.010.0%0.040.3%0.030.2%0.070.4%0.070.4%
Usd Dividend Per Share0.000.0%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.010.1%0.050.3%0.040.2%0.080.5%0.080.5%
Usd Price Per Share2.59-3.40-5.15-4.96-4.96-
Price to Earnings Ratio169.82-73.51-50.27-65.77-65.77-
Price-to-Total Gains Ratio253.97-121.41-148.28-137.04-137.04-
Price to Book Ratio2.09-2.81-4.92-5.74-5.74-
Price-to-Total Gains Ratio253.97-121.41-148.28-137.04-137.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.192256
Number of shares456
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.040.07
Usd Total Gains Per Share0.050.08
Gains per Quarter (456 shares)22.6935.13
Gains per Year (456 shares)90.77140.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
117748121119131
23414717242239272
35122126364358413
46829535485477554
586368445106597695
6103442536127716836
7120516627148835977
81375897181699551118
915466380919110741259
1017173790021211931400

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%15.04.00.078.9%15.04.00.078.9%15.04.00.078.9%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%18.01.00.094.7%18.01.00.094.7%18.01.00.094.7%

Fundamentals of Zhejiang Anglikang Pharmaceutical Co Ltd Class A

About Zhejiang Anglikang Pharmaceutical Co Ltd Class A

Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, antihypertensive, digestive system, central nervous diseases, and respiratory preparations. The company was founded in 2001 and is based in Shengzhou, China.

Fundamental data was last updated by Penke on 2024-03-11 01:56:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Zhejiang Anglikang Pharmaceutical Co Ltd Class A.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Anglikang Pharmaceutical Co Ltd Class A earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Anglikang Pharmaceutical Co Ltd Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 1.6% means that ¥0.02 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Anglikang Pharmaceutical Co Ltd Class A:

  • The MRQ is 1.6%. The company is making a profit. +1
  • The TTM is 7.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.6%TTM7.5%-5.9%
TTM7.5%YOY10.5%-3.0%
TTM7.5%5Y9.4%-1.9%
5Y9.4%10Y9.4%0.0%
1.1.2. Return on Assets

Shows how efficient Zhejiang Anglikang Pharmaceutical Co Ltd Class A is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Anglikang Pharmaceutical Co Ltd Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.2% Return on Assets means that Zhejiang Anglikang Pharmaceutical Co Ltd Class A generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Anglikang Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.2%TTM1.1%-0.9%
TTM1.1%YOY1.7%-0.6%
TTM1.1%5Y1.8%-0.7%
5Y1.8%10Y1.8%0.0%
1.1.3. Return on Equity

Shows how efficient Zhejiang Anglikang Pharmaceutical Co Ltd Class A is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Anglikang Pharmaceutical Co Ltd Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.4% Return on Equity means Zhejiang Anglikang Pharmaceutical Co Ltd Class A generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Anglikang Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.4%TTM2.1%-1.7%
TTM2.1%YOY2.8%-0.7%
TTM2.1%5Y2.8%-0.7%
5Y2.8%10Y2.8%0.0%

1.2. Operating Efficiency of Zhejiang Anglikang Pharmaceutical Co Ltd Class A.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Anglikang Pharmaceutical Co Ltd Class A is operating .

  • Measures how much profit Zhejiang Anglikang Pharmaceutical Co Ltd Class A makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Anglikang Pharmaceutical Co Ltd Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Anglikang Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM7.6%-7.6%
TTM7.6%YOY10.6%-3.0%
TTM7.6%5Y10.9%-3.4%
5Y10.9%10Y10.9%0.0%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Anglikang Pharmaceutical Co Ltd Class A is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.56 means that the operating costs are ¥1.56 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Anglikang Pharmaceutical Co Ltd Class A:

  • The MRQ is 1.562. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.427. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.562TTM1.427+0.136
TTM1.427YOY1.277+0.149
TTM1.4275Y1.236+0.191
5Y1.23610Y1.2360.000

1.3. Liquidity of Zhejiang Anglikang Pharmaceutical Co Ltd Class A.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Anglikang Pharmaceutical Co Ltd Class A is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.99 means the company has ¥1.99 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Anglikang Pharmaceutical Co Ltd Class A:

  • The MRQ is 1.988. The company is able to pay all its short-term debts. +1
  • The TTM is 1.944. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.988TTM1.944+0.044
TTM1.944YOY1.863+0.081
TTM1.9445Y2.331-0.387
5Y2.33110Y2.3310.000
1.3.2. Quick Ratio

Measures if Zhejiang Anglikang Pharmaceutical Co Ltd Class A is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Anglikang Pharmaceutical Co Ltd Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.18 means the company can pay off ¥0.18 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Anglikang Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.178. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.391. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.178TTM0.391-0.213
TTM0.391YOY0.425-0.033
TTM0.3915Y0.461-0.070
5Y0.46110Y0.4610.000

1.4. Solvency of Zhejiang Anglikang Pharmaceutical Co Ltd Class A.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Anglikang Pharmaceutical Co Ltd Class A assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Anglikang Pharmaceutical Co Ltd Class A to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.44 means that Zhejiang Anglikang Pharmaceutical Co Ltd Class A assets are financed with 43.5% credit (debt) and the remaining percentage (100% - 43.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Anglikang Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.435. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.391. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.435TTM0.391+0.045
TTM0.391YOY0.329+0.061
TTM0.3915Y0.312+0.079
5Y0.31210Y0.3120.000
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Anglikang Pharmaceutical Co Ltd Class A is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Anglikang Pharmaceutical Co Ltd Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 88.7% means that company has ¥0.89 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Anglikang Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.887. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.735. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.887TTM0.735+0.151
TTM0.735YOY0.542+0.193
TTM0.7355Y0.503+0.232
5Y0.50310Y0.5030.000

2. Market Valuation of Zhejiang Anglikang Pharmaceutical Co Ltd Class A

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Anglikang Pharmaceutical Co Ltd Class A generates.

  • Above 15 is considered overpriced but always compare Zhejiang Anglikang Pharmaceutical Co Ltd Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 169.82 means the investor is paying ¥169.82 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Anglikang Pharmaceutical Co Ltd Class A:

  • The EOD is 143.545. Based on the earnings, the company is expensive. -2
  • The MRQ is 169.825. Based on the earnings, the company is expensive. -2
  • The TTM is 73.513. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD143.545MRQ169.825-26.280
MRQ169.825TTM73.513+96.312
TTM73.513YOY50.275+23.238
TTM73.5135Y65.768+7.744
5Y65.76810Y65.7680.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Anglikang Pharmaceutical Co Ltd Class A:

  • The EOD is 15.187. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 17.967. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 6.289. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD15.187MRQ17.967-2.780
MRQ17.967TTM6.289+11.678
TTM6.289YOY3.082+3.208
TTM6.2895Y29.254-22.965
5Y29.25410Y29.2540.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Anglikang Pharmaceutical Co Ltd Class A is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Anglikang Pharmaceutical Co Ltd Class A:

  • The EOD is 1.764. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.087. Based on the equity, the company is underpriced. +1
  • The TTM is 2.810. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.764MRQ2.087-0.323
MRQ2.087TTM2.810-0.724
TTM2.810YOY4.924-2.114
TTM2.8105Y5.741-2.931
5Y5.74110Y5.7410.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Anglikang Pharmaceutical Co Ltd Class A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0480.292-84%0.195-75%0.473-90%0.473-90%
Book Value Per Share--8.9818.767+2%7.560+19%6.746+33%6.746+33%
Current Ratio--1.9881.944+2%1.863+7%2.331-15%2.331-15%
Debt To Asset Ratio--0.4350.391+11%0.329+32%0.312+40%0.312+40%
Debt To Equity Ratio--0.8870.735+21%0.542+64%0.503+76%0.503+76%
Dividend Per Share--0.0260.068-62%0.058-56%0.084-69%0.084-69%
Eps--0.0280.160-83%0.190-85%0.165-83%0.165-83%
Free Cash Flow Per Share--0.2610.191+36%0.228+14%0.175+49%0.175+49%
Free Cash Flow To Equity Per Share--0.2610.335-22%0.486-46%0.271-4%0.271-4%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--8.172--------
Intrinsic Value_10Y_min--7.043--------
Intrinsic Value_1Y_max--0.729--------
Intrinsic Value_1Y_min--0.716--------
Intrinsic Value_3Y_max--2.259--------
Intrinsic Value_3Y_min--2.155--------
Intrinsic Value_5Y_max--3.872--------
Intrinsic Value_5Y_min--3.588--------
Market Cap3195371520.000-18%3780386205.6404950911204.675-24%7505285196.800-50%7232157269.868-48%7232157269.868-48%
Net Profit Margin--0.0160.075-78%0.105-85%0.094-83%0.094-83%
Operating Margin---0.076-100%0.106-100%0.109-100%0.109-100%
Operating Ratio--1.5621.427+10%1.277+22%1.236+26%1.236+26%
Pb Ratio1.764-18%2.0872.810-26%4.924-58%5.741-64%5.741-64%
Pe Ratio143.545-18%169.82573.513+131%50.275+238%65.768+158%65.768+158%
Price Per Share15.840-18%18.74024.543-24%37.205-50%35.851-48%35.851-48%
Price To Free Cash Flow Ratio15.187-18%17.9676.289+186%3.082+483%29.254-39%29.254-39%
Price To Total Gains Ratio214.672-18%253.975121.407+109%148.285+71%137.040+85%137.040+85%
Quick Ratio--0.1780.391-54%0.425-58%0.461-61%0.461-61%
Return On Assets--0.0020.011-84%0.017-90%0.018-90%0.018-90%
Return On Equity--0.0040.021-83%0.028-87%0.028-87%0.028-87%
Total Gains Per Share--0.0740.360-79%0.254-71%0.557-87%0.557-87%
Usd Book Value--250745247.671244754822.860+2%211063018.895+19%188350055.121+33%188350055.121+33%
Usd Book Value Change Per Share--0.0070.040-84%0.027-75%0.065-90%0.065-90%
Usd Book Value Per Share--1.2431.213+2%1.046+19%0.934+33%0.934+33%
Usd Dividend Per Share--0.0040.009-62%0.008-56%0.012-69%0.012-69%
Usd Eps--0.0040.022-83%0.026-85%0.023-83%0.023-83%
Usd Free Cash Flow--7279933.8955344877.210+36%6374318.065+14%4878920.003+49%4878920.003+49%
Usd Free Cash Flow Per Share--0.0360.026+36%0.032+14%0.024+49%0.024+49%
Usd Free Cash Flow To Equity Per Share--0.0360.046-22%0.067-46%0.038-4%0.038-4%
Usd Market Cap442239418.368-18%523205450.861685206110.727-24%1038731471.237-50%1000930566.150-48%1000930566.150-48%
Usd Price Per Share2.192-18%2.5943.397-24%5.149-50%4.962-48%4.962-48%
Usd Profit--770213.3354456976.633-83%5291236.664-85%4610347.198-83%4610347.198-83%
Usd Revenue--47566982.17758553774.872-19%50398558.737-6%49690246.203-4%49690246.203-4%
Usd Total Gains Per Share--0.0100.050-79%0.035-71%0.077-87%0.077-87%
 EOD+4 -4MRQTTM+10 -25YOY+10 -255Y+10 -2510Y+10 -25

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Anglikang Pharmaceutical Co Ltd Class A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15143.545
Price to Book Ratio (EOD)Between0-11.764
Net Profit Margin (MRQ)Greater than00.016
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.178
Current Ratio (MRQ)Greater than11.988
Debt to Asset Ratio (MRQ)Less than10.435
Debt to Equity Ratio (MRQ)Less than10.887
Return on Equity (MRQ)Greater than0.150.004
Return on Assets (MRQ)Greater than0.050.002
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Anglikang Pharmaceutical Co Ltd Class A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.794
Ma 20Greater thanMa 5016.271
Ma 50Greater thanMa 10016.427
Ma 100Greater thanMa 20018.761
OpenGreater thanClose15.860
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Tax Provision  2,7161,7754,4912,2966,787-2,4384,349-4,559-210
Interest Income  3,83326,09629,929-25,7474,1829,74013,922-39,058-25,136



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,207,490
Total Liabilities1,395,747
Total Stockholder Equity1,574,396
 As reported
Total Liabilities 1,395,747
Total Stockholder Equity+ 1,574,396
Total Assets = 3,207,490

Assets

Total Assets3,207,490
Total Current Assets1,774,428
Long-term Assets1,433,062
Total Current Assets
Cash And Cash Equivalents 989,050
Short-term Investments 15,000
Net Receivables 143,995
Inventory 480,570
Other Current Assets 25,102
Total Current Assets  (as reported)1,774,428
Total Current Assets  (calculated)1,653,717
+/- 120,712
Long-term Assets
Property Plant Equipment 582,582
Goodwill 309,093
Intangible Assets 170,307
Long-term Assets Other 14,384
Long-term Assets  (as reported)1,433,062
Long-term Assets  (calculated)1,076,366
+/- 356,696

Liabilities & Shareholders' Equity

Total Current Liabilities892,662
Long-term Liabilities503,086
Total Stockholder Equity1,574,396
Total Current Liabilities
Short Long Term Debt 126,707
Accounts payable 534,790
Other Current Liabilities 4,081
Total Current Liabilities  (as reported)892,662
Total Current Liabilities  (calculated)665,577
+/- 227,085
Long-term Liabilities
Long term Debt 470,750
Capital Lease Obligations Min Short Term Debt165
Long-term Liabilities  (as reported)503,086
Long-term Liabilities  (calculated)470,915
+/- 32,171
Total Stockholder Equity
Retained Earnings 587,727
Total Stockholder Equity (as reported)1,574,396
Total Stockholder Equity (calculated)587,727
+/- 986,669
Other
Capital Stock201,728
Common Stock Shares Outstanding 201,728
Net Invested Capital 2,171,852
Net Working Capital 881,767
Property Plant and Equipment Gross 582,582



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
> Total Assets 
0
1,449,788
1,376,822
1,331,419
1,384,985
1,466,811
1,395,450
1,471,154
1,940,754
1,881,860
1,929,142
1,896,558
2,083,578
2,245,360
2,356,717
2,427,817
2,596,083
2,901,032
2,937,603
3,207,490
3,207,4902,937,6032,901,0322,596,0832,427,8172,356,7172,245,3602,083,5781,896,5581,929,1421,881,8601,940,7541,471,1541,395,4501,466,8111,384,9851,331,4191,376,8221,449,7880
   > Total Current Assets 
0
1,055,539
980,357
934,861
977,661
1,049,317
958,734
1,013,091
1,393,397
1,316,295
1,373,407
1,234,926
1,375,956
1,349,357
1,211,140
1,284,732
1,451,957
1,519,931
1,538,234
1,774,428
1,774,4281,538,2341,519,9311,451,9571,284,7321,211,1401,349,3571,375,9561,234,9261,373,4071,316,2951,393,3971,013,091958,7341,049,317977,661934,861980,3571,055,5390
       Cash And Cash Equivalents 
0
642,119
592,555
586,667
527,697
698,513
576,246
621,007
854,066
831,311
859,174
734,779
688,908
702,658
560,849
606,050
735,467
670,923
697,330
989,050
989,050697,330670,923735,467606,050560,849702,658688,908734,779859,174831,311854,066621,007576,246698,513527,697586,667592,555642,1190
       Short-term Investments 
0
0
0
0
100,054
0
0
0
0
0
0
0
59,600
38,000
30,000
22,000
69,297
67,297
59,392
15,000
15,00059,39267,29769,29722,00030,00038,00059,6000000000100,0540000
       Net Receivables 
0
201,040
179,450
130,964
204,725
182,970
171,940
185,252
271,239
238,109
214,462
226,184
318,591
222,605
246,468
237,311
302,277
322,757
266,708
143,995
143,995266,708322,757302,277237,311246,468222,605318,591226,184214,462238,109271,239185,252171,940182,970204,725130,964179,450201,0400
       Other Current Assets 
0
2,193
7,115
11,013
6,180
13,879
22,357
25,613
5,094
14,168
9,865
26,421
9,254
22,163
8,636
48,072
51,687
31,299
43,519
25,102
25,10243,51931,29951,68748,0728,63622,1639,25426,4219,86514,1685,09425,61322,35713,8796,18011,0137,1152,1930
   > Long-term Assets 
0
394,249
396,465
396,557
407,325
417,494
436,716
458,063
547,358
565,564
555,735
661,632
707,623
896,002
1,145,577
1,143,084
1,144,126
1,381,101
1,399,368
1,433,062
1,433,0621,399,3681,381,1011,144,1261,143,0841,145,577896,002707,623661,632555,735565,564547,358458,063436,716417,494407,325396,557396,465394,2490
       Property Plant Equipment 
272,538
279,196
288,784
290,326
304,581
305,037
328,920
350,877
389,508
385,889
382,755
455,861
474,634
455,104
444,205
442,459
445,703
581,680
577,060
582,582
582,582577,060581,680445,703442,459444,205455,104474,634455,861382,755385,889389,508350,877328,920305,037304,581290,326288,784279,196272,538
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
7,413
21,976
21,976
21,976
21,976
21,976
323,998
309,093
309,093
309,093309,093323,99821,97621,97621,97621,97621,9767,41300000000000
       Intangible Assets 
0
39,671
2,653
39,338
38,865
38,369
37,872
37,377
36,881
36,386
35,891
40,688
40,055
39,445
39,092
38,821
38,779
106,714
143,875
170,307
170,307143,875106,71438,77938,82139,09239,44540,05540,68835,89136,38636,88137,37737,87238,36938,86539,3382,65339,6710
       Long-term Assets Other 
0
24,700
24,700
24,700
19,900
19,900
19,900
350,877
0
0
0
0
0
0
2,896
0
297,732
13,343
11,358
14,384
14,38411,35813,343297,73202,896000000350,87719,90019,90019,90024,70024,70024,7000
> Total Liabilities 
0
442,767
403,355
341,909
368,513
406,134
376,618
408,878
562,784
476,083
576,619
477,704
608,643
726,146
827,101
851,494
949,927
1,087,168
1,135,527
1,395,747
1,395,7471,135,5271,087,168949,927851,494827,101726,146608,643477,704576,619476,083562,784408,878376,618406,134368,513341,909403,355442,7670
   > Total Current Liabilities 
0
429,584
390,898
327,717
355,171
388,954
358,961
392,243
545,190
459,562
561,172
462,963
595,286
713,797
765,418
770,786
788,589
859,186
706,370
892,662
892,662706,370859,186788,589770,786765,418713,797595,286462,963561,172459,562545,190392,243358,961388,954355,171327,717390,898429,5840
       Short-term Debt 
0
0
0
0
0
10,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000010,00000000
       Short Long Term Debt 
0
0
0
0
0
10,000
10,006
10,006
10,006
0
0
0
0
120,000
140,137
160,146
170,178
94,046
64,181
126,707
126,70764,18194,046170,178160,146140,137120,000000010,00610,00610,00610,00000000
       Accounts payable 
0
206,971
170,907
138,956
144,322
121,324
165,494
165,203
322,731
268,803
340,134
275,277
335,975
380,246
387,335
358,643
320,450
368,213
419,223
534,790
534,790419,223368,213320,450358,643387,335380,246335,975275,277340,134268,803322,731165,203165,494121,324144,322138,956170,907206,9710
       Other Current Liabilities 
0
0
0
171,394
25,982
247,717
21,434
203,013
28,394
178,579
67,447
168,058
38,885
199,513
29,302
228,809
57,195
349,005
45,552
4,081
4,08145,552349,00557,195228,80929,302199,51338,885168,05867,447178,57928,394203,01321,434247,71725,982171,394000
   > Long-term Liabilities 
0
13,182
12,458
14,191
13,342
17,179
17,658
16,634
17,594
16,521
15,448
14,741
13,357
12,349
61,683
80,708
161,338
227,982
429,157
503,086
503,086429,157227,982161,33880,70861,68312,34913,35714,74115,44816,52117,59416,63417,65817,17913,34214,19112,45813,1820
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
-10,000
0
0
0
0
0
0
0
0
0
0
0
276
159
165
16515927600000000000-10,00000000
       Deferred Long Term Liability 
319
316
1,012
1,273
1,260
1,862
1,692
1,751
1,569
1,387
0
1,637
1,603
1,405
1,214
1,268
985
4,345
3,676
0
03,6764,3459851,2681,2141,4051,6031,63701,3871,5691,7511,6921,8621,2601,2731,012316319
> Total Stockholder Equity
0
953,055
917,712
943,415
965,125
1,007,005
960,049
998,938
1,318,879
1,342,892
1,283,150
1,292,985
1,338,853
1,378,140
1,399,120
1,432,425
1,502,661
1,553,408
1,572,282
1,574,396
1,574,3961,572,2821,553,4081,502,6611,432,4251,399,1201,378,1401,338,8531,292,9851,283,1501,342,8921,318,879998,938960,0491,007,005965,125943,415917,712953,0550
   Common Stock
90,000
90,000
90,000
90,000
90,000
90,000
90,000
90,000
95,947
95,947
95,947
95,947
95,947
95,947
95,947
95,947
139,123
139,123
201,728
0
0201,728139,123139,12395,94795,94795,94795,94795,94795,94795,94795,94790,00090,00090,00090,00090,00090,00090,00090,000
   Retained Earnings Total Equity00000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
550
929
1,326
1,696
1,837
1,923
1,690
1,422
837
1,147
1,452
1,672
2,638
2,838
3,875
4,688
2,754
4,621
6,262
0
06,2624,6212,7544,6883,8752,8382,6381,6721,4521,1478371,4221,6901,9231,8371,6961,326929550



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue-
Cost of Revenue-888,416
Gross Profit--888,416
 
Operating Income (+$)
Gross Profit-
Operating Expense-1,514,060
Operating Income178,246-1,514,060
 
Operating Expense (+$)
Research Development-
Selling General Administrative438,716
Selling And Marketing Expenses-
Operating Expense1,514,060438,716
 
Net Interest Income (+$)
Interest Income14,533
Interest Expense-12,583
Other Finance Cost-7,066
Net Interest Income9,016
 
Pretax Income (+$)
Operating Income178,246
Net Interest Income9,016
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-178,246
EBIT - interestExpense = -12,583
128,814
141,398
Interest Expense12,583
Earnings Before Interest and Taxes (EBIT)-12,583
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-
Tax Provision-15,416
Net Income From Continuing Ops159,436-15,416
Net Income128,814
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--9,016
 

Technical Analysis of Zhejiang Anglikang Pharmaceutical Co Ltd Class A
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. The general trend of Zhejiang Anglikang Pharmaceutical Co Ltd Class A is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Anglikang Pharmaceutical Co Ltd Class A's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Anglikang Pharmaceutical Co Ltd Class A.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 17.08 < 17.22 < 17.29.

The bearish price targets are: 15.51 > 11.84.

Tweet this
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. The current macd is -0.13266686.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhejiang Anglikang Pharmaceutical Co Ltd Class A price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Zhejiang Anglikang Pharmaceutical Co Ltd Class A. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Zhejiang Anglikang Pharmaceutical Co Ltd Class A price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. The current adx is 20.81.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Zhejiang Anglikang Pharmaceutical Co Ltd Class A shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. The current sar is 17.09.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. The current rsi is 43.79. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Relative Strength Index (RSI) ChartZhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Anglikang Pharmaceutical Co Ltd Class A price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Stochastic Oscillator ChartZhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. The current cci is -84.02437083.

Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Commodity Channel Index (CCI) ChartZhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. The current cmo is -18.33452906.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Chande Momentum Oscillator (CMO) ChartZhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. The current willr is -80.70175439.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Williams %R ChartZhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Anglikang Pharmaceutical Co Ltd Class A.

Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. The current atr is 0.61646732.

Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Average True Range (ATR) ChartZhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. The current obv is 63,538,376.

Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily On-Balance Volume (OBV) ChartZhejiang Anglikang Pharmaceutical Co Ltd Class A Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Anglikang Pharmaceutical Co Ltd Class A. The current mfi is 43.87.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Money Flow Index (MFI) ChartZhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Anglikang Pharmaceutical Co Ltd Class A.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Zhejiang Anglikang Pharmaceutical Co Ltd Class A Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Anglikang Pharmaceutical Co Ltd Class A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.794
Ma 20Greater thanMa 5016.271
Ma 50Greater thanMa 10016.427
Ma 100Greater thanMa 20018.761
OpenGreater thanClose15.860
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Anglikang Pharmaceutical Co Ltd Class A with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Anglikang Pharmaceutical Co Ltd Class A? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Anglikang Pharmaceutical Co Ltd Class A? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Anglikang Pharmaceutical Co Ltd Class A

I send you an email if I find something interesting about Zhejiang Anglikang Pharmaceutical Co Ltd Class A.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Anglikang Pharmaceutical Co Ltd Class A.

Receive notifications about Zhejiang Anglikang Pharmaceutical Co Ltd Class A in your mailbox!